Indivior (INDV) RNS Announcements

Add to Alert list
Date Time Source Announcement
02 Nov 2017 11:40 AM
RNS
Holding(s) in Company
02 Nov 2017 11:00 AM
RNS
3rd Quarter Results
01 Nov 2017 07:00 AM
RNS
FDA Advisory Committees Vote to Approve RBP-6000
10 Oct 2017 07:00 AM
RNS
Notice of Results
09 Oct 2017 01:17 PM
RNS
Holding(s) in Company
03 Oct 2017 04:00 PM
RNS
FDA Posts Advisory Committee Notice for RBP-6000
02 Oct 2017 07:00 AM
RNS
RBP-7000 - Submission of NDA to U.S. FDA
25 Sep 2017 07:00 AM
RNS
Indivior settlement with Mylan Pharmaceuticals
21 Sep 2017 03:36 PM
RNS
Holding(s) in Company
21 Sep 2017 09:37 AM
RNS
Holding(s) in Company
15 Sep 2017 07:00 AM
RNS
Indivior asserts new patent against ANDA-filers
11 Sep 2017 09:50 AM
RNS
Holding(s) in Company
01 Sep 2017 03:04 PM
RNS
Total Voting Rights
01 Sep 2017 07:00 AM
RNS
Indivior to appeal court rulings ANDA litigation
31 Aug 2017 05:21 PM
RNS
Holding(s) in Company
30 Aug 2017 05:00 PM
RNS
Morgan Stanley Annual Global Healthcare Conference
14 Aug 2017 07:00 AM
RNS
Holding(s) in Company
10 Aug 2017 04:36 PM
RNS
Director/PDMR Shareholding (Replacement)
10 Aug 2017 04:00 PM
RNS
Director/PDMR Shareholding
08 Aug 2017 11:24 AM
RNS
Holding(s) in Company
08 Aug 2017 11:16 AM
RNS
Holding(s) in Company
08 Aug 2017 11:14 AM
RNS
Holding(s) in Company
08 Aug 2017 11:10 AM
RNS
Holding(s) in Company
02 Aug 2017 11:08 AM
RNS
Holding(s) in Company
01 Aug 2017 07:00 AM
RNS
Total Voting Rights
31 Jul 2017 03:58 PM
RNS
Holding(s) in Company
31 Jul 2017 07:30 AM
RNS
Indivior's NALSCUE® Receives ANSM MA for France
31 Jul 2017 07:00 AM
RNS
RBP-6000 NDA Receives FDA Priority Review
27 Jul 2017 07:00 AM
RNS
Half Year Financial Results
13 Jul 2017 02:00 PM
RNS
Notice of Results
29 Jun 2017 11:00 AM
RNS
RBP-6000 Investor Event Reminder
16 Jun 2017 02:00 PM
RNS
RBP-6000 Investor Event
02 Jun 2017 09:25 AM
RNS
Block Listing Six Monthly Return
01 Jun 2017 03:16 PM
RNS
Total Voting Rights
30 May 2017 04:24 PM
RNS
RBP-6000 - Submission of NDA to U.S. FDA
23 May 2017 05:00 PM
RNS
Jefferies Global Healthcare Conference
17 May 2017 05:36 PM
RNS
Result of AGM
10 May 2017 04:04 PM
RNS
Block Listing Six Monthly Return
03 May 2017 12:00 PM
RNS
1st Quarter Results
19 Apr 2017 02:00 PM
RNS
Notice of Results
07 Apr 2017 09:58 AM
RNS
Holding(s) in Company
28 Mar 2017 02:00 PM
RNS
Additional RBP-6000 Clinical Study Results
23 Mar 2017 01:00 PM
RNS
Annual Financial Report
13 Mar 2017 12:00 PM
RNS
Top-line Phase 3 Trial Results - RBP-7000
07 Mar 2017 05:29 PM
RNS
Director Resignation
27 Feb 2017 01:50 PM
RNS
Director/PDMR Shareholding
27 Feb 2017 01:22 PM
RNS
Director/PDMR Shareholding
22 Feb 2017 07:00 AM
RNS
Directorate Change
22 Feb 2017 07:00 AM
RNS
Full Year Financial Results
15 Feb 2017 05:04 PM
RNS
Director Declaration

Indivior is a pharmaceutical company that develops and sells treatments for addiction and other serious mental illnesses.

Founded in 1994 as a division of Reckitt Benckiser and demerged in 2014, Indivior is listed on the London Stock Exchange and the NASDAQ Global Select Market.

Indivior share price is listed in London under the ticker INDV.

UK 100